Inactive Instrument
Quest PharmaTech Inc Share Price Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 33.83L 24.36L 20.91L 19.62L 17.92L 23Cr 33.99L 2.32Cr 90L 12Cr 91.46L 89.48L 39Cr | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 43.68L 31.46L 27L 25.34L 23.15L 30Cr 43.89L 3Cr 1.16Cr 15Cr 1.18Cr 1.16Cr 50Cr | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 24.36L | |
| -0.29% | -0.14% | +2.20% | +23.03% | 5.1TCr | |
| +1.92% | +0.36% | +477.97% | +550.09% | 4.62TCr | |
| -0.15% | -0.28% | +21.65% | +89.41% | 4.27TCr | |
| +0.81% | +4.91% | +39.28% | +19.41% | 4.3TCr | |
| -2.27% | -3.02% | +14.22% | +51.50% | 3.35TCr | |
| +0.81% | +1.77% | +31.91% | +138.26% | 1.73TCr | |
| -1.08% | -3.61% | - | - | 1.64TCr | |
| -0.38% | -0.38% | +11.33% | +28.07% | 1.47TCr | |
| -0.85% | +1.76% | +80.26% | +47.26% | 1.41TCr | |
| Average | -0.39% | +1.33% | +84.85% | +118.38% | 3.1TCr | |
| Weighted average by Cap. | -0.38% | +1.16% | +103.34% | +138.76% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -18.01L -12.97L -11.13L -10.45L -10L -12Cr -18.1L -1.24Cr -47.92L -6.24Cr -48.7L -47.64L -21Cr | 49.98L 36L 30.9L 29L 26.48L 34Cr 50.22L 3.43Cr 1.33Cr 17Cr 1.35Cr 1.32Cr 57Cr |
| Net Debt | 8L 6L 5L 5L 4L 5.46Cr 8L 54.58L 21.15L 2.75Cr 21.49L 21.03L 9.12Cr | 10L 7L 6L 6L 5L 6.77Cr 10L 67.67L 26.23L 3.42Cr 26.65L 26.07L 11Cr |
Employees
-
